Press review

 - 

New general manager appointed at Pierre Fabre

Country : France

Keywords :
PARIS, May 11 (APM) - Pierre Fabre has appointed Eric Ducournau to the post of general manager.
He is currently head of the skincare division and will replace on 2nd July Bertrand Parmentier, who is retiring, Tuesday’s Les Echos reported.

Lilly buys Armo Biosciences for $1.6 billion

Lilly is buying cancer specialist Armo Biosciences for $1.6 billion to boost its presence in immuno-oncology, reports on Friday Les Echos (brief p16), Le Monde (Economy and Enterprises, brief p5) and Le Figaro (brief p22).

Takeda makes firm offer to acquire Shire

Wednesday’s Les Echos (brief p16), Le Monde (Economy and Enterprises supplement, brief p5) and Le Figaro (brief p22) briefly reported on the firm offer submitted by Takeda on Shire for £46 billion (APMHE 58007).

Christophe Durand takes helm of Biopharmaceuticals branch of Celgene France

Christophe Durand has been appointed general manager of the biopharmaceuticals unit of Celgene France, reported Le Figaro (brief p20) on Wednesday.
He replaces Yannick Sabatin and was previously head of Alexion France and Benelux.
cm/nh

[NH2P8K5LZ]

TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT

Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations

Events coverage with a unique focus on Market Access & sustainability of healthcare systems

6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris

Ask for a Free trial and get access to our last stories

Request a trial to assess coverage that includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.

REQUEST

an initial 10 day temporary access of APM Health Europe.